Therapeutic Education and Nursing Support Program for Supportive Care, in Patients Treated With Hormone Therapy for Non-metastatic Breast Cancer

Who May Qualify: - Female patients aged 18 to 75 years inclusive - Patients with non-metastatic breast cancer for whom adjuvant hormone therapy (anti-oestrogen or anti-aromatase) is indicated, depending on the decision of the multidisciplinary consultation meeting. - Performance status (ECOG) ≤ 2 - Patient able to read and understand French (common use) - Patient with access to an internet connection (for collection of adverse events and responses to questionnaires on the electronic platform) - Patient who has been informed and has given written consent to participate in the study - Patient affiliated to the French social security system or equivalent Who Should NOT Join This Trial: - Patient with metastatic cancer (stage IV) - Patient undergoing neoadjuvant hormone therapy - Patient who started hormone therapy prior to inclusion in the study - Patient with a history of other cancer treated by radiotherapy, chemotherapy or hormone therapy, with an end of treatment less than 2 years ago. - For patients in the experimental group: Inability of the patient to travel to the hospital to attend the initial assessment day and the proposed group outpatient workshops; follow-up of the program difficult for geographical, physical or other reasons (at the discretion of the investigator). - For patients in the control group: patients for whom telephone nursing follow-up is planned for 2 months or more or more than 4 sessions of therapeutic education. - Pregnant and breastfeeding women - Patient with a documented history of cognitive or psychiatric disorders - Refusal to participate, protected adult patient, under guardianship or curatorship Always talk to your doctor about whether this trial is right for you.